1. 1) Collins, F.S. and Varmus, H. (2015) A new initiative on precision medicine. N. Engl. J. Med. 372, 793–795.
2. 2) Scott, A.M., Wolchok, J.D. and Old, L.J. (2012) Antibody therapy of cancer. Nat. Rev. Cancer 12, 278–287.
3. 3) Beck, A., Goetsch, L., Dumontet, C. and Corvaïa, N. (2017) Strategies and challenges for the next generation of antibody–drug conjugates. Nat. Rev. Drug Discov. 16, 315–337.
4. 4) Larson, S.M., Carrasquillo, J.A., Cheung, N.K.V. and Press, O.W. (2015) Radioimmunotherapy of human tumours. Nat. Rev. Cancer 15, 347–360.
5. 5) Goldenberg, D.M., Sharkey, R.M., Paganelli, G., Barbet, J. and Chatal, J.F. (2006) Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J. Clin. Oncol. 24, 823–834.